vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and DAKTRONICS INC (DAKT). Click either name above to swap in a different company.

ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $229.3M, roughly 1.2× DAKTRONICS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 7.6%, a 88.7% gap on every dollar of revenue. On growth, DAKTRONICS INC posted the faster year-over-year revenue change (10.0% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 16.0%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Daktronics, Inc. is an American company based in Brookings, South Dakota, that designs, manufactures, sells, and services video displays, scoreboards, digital billboards, dynamic message signs, sound systems, and related products. It was founded in 1968 by two South Dakota State University professors.

ACAD vs DAKT — Head-to-Head

Bigger by revenue
ACAD
ACAD
1.2× larger
ACAD
$284.0M
$229.3M
DAKT
Growing faster (revenue YoY)
DAKT
DAKT
+0.6% gap
DAKT
10.0%
9.4%
ACAD
Higher net margin
ACAD
ACAD
88.7% more per $
ACAD
96.3%
7.6%
DAKT
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
17.5%
16.0%
DAKT

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ACAD
ACAD
DAKT
DAKT
Revenue
$284.0M
$229.3M
Net Profit
$273.6M
$17.5M
Gross Margin
90.8%
27.0%
Operating Margin
6.1%
9.4%
Net Margin
96.3%
7.6%
Revenue YoY
9.4%
10.0%
Net Profit YoY
90.3%
-18.3%
EPS (diluted)
$1.61
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
DAKT
DAKT
Q4 25
$284.0M
$229.3M
Q3 25
$278.6M
$219.0M
Q2 25
$264.6M
$172.6M
Q1 25
$244.3M
$149.5M
Q4 24
$259.6M
$208.3M
Q3 24
$250.4M
$226.1M
Q2 24
$242.0M
$215.9M
Q1 24
$205.8M
$170.3M
Net Profit
ACAD
ACAD
DAKT
DAKT
Q4 25
$273.6M
$17.5M
Q3 25
$71.8M
$16.5M
Q2 25
$26.7M
$-9.4M
Q1 25
$19.0M
$-17.2M
Q4 24
$143.7M
$21.4M
Q3 24
$32.8M
$-4.9M
Q2 24
$33.4M
$2.5M
Q1 24
$16.6M
$10.7M
Gross Margin
ACAD
ACAD
DAKT
DAKT
Q4 25
90.8%
27.0%
Q3 25
92.2%
29.7%
Q2 25
92.2%
25.0%
Q1 25
91.7%
24.6%
Q4 24
91.6%
26.8%
Q3 24
92.5%
26.4%
Q2 24
92.5%
25.7%
Q1 24
88.8%
24.5%
Operating Margin
ACAD
ACAD
DAKT
DAKT
Q4 25
6.1%
9.4%
Q3 25
12.8%
10.6%
Q2 25
12.2%
-1.0%
Q1 25
7.9%
-2.4%
Q4 24
59.1%
7.6%
Q3 24
12.6%
10.0%
Q2 24
12.6%
9.0%
Q1 24
7.4%
4.7%
Net Margin
ACAD
ACAD
DAKT
DAKT
Q4 25
96.3%
7.6%
Q3 25
25.8%
7.5%
Q2 25
10.1%
-5.5%
Q1 25
7.8%
-11.5%
Q4 24
55.4%
10.3%
Q3 24
13.1%
-2.2%
Q2 24
13.8%
1.2%
Q1 24
8.0%
6.3%
EPS (diluted)
ACAD
ACAD
DAKT
DAKT
Q4 25
$1.61
$0.35
Q3 25
$0.42
$0.33
Q2 25
$0.16
$0.04
Q1 25
$0.11
$-0.36
Q4 24
$0.86
$0.22
Q3 24
$0.20
$-0.11
Q2 24
$0.20
$0.18
Q1 24
$0.10
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
DAKT
DAKT
Cash + ST InvestmentsLiquidity on hand
$177.7M
$149.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.2B
$297.5M
Total Assets
$1.6B
$548.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
DAKT
DAKT
Q4 25
$177.7M
$149.6M
Q3 25
$258.0M
$136.9M
Q2 25
$253.6M
$127.5M
Q1 25
$217.7M
$132.2M
Q4 24
$319.6M
$134.4M
Q3 24
$155.1M
$96.8M
Q2 24
$177.1M
$81.3M
Q1 24
$204.7M
$76.8M
Stockholders' Equity
ACAD
ACAD
DAKT
DAKT
Q4 25
$1.2B
$297.5M
Q3 25
$917.3M
$279.8M
Q2 25
$822.4M
$271.9M
Q1 25
$765.2M
$272.3M
Q4 24
$732.8M
$260.9M
Q3 24
$577.2M
$238.2M
Q2 24
$516.7M
$238.8M
Q1 24
$464.0M
$236.2M
Total Assets
ACAD
ACAD
DAKT
DAKT
Q4 25
$1.6B
$548.4M
Q3 25
$1.3B
$545.6M
Q2 25
$1.2B
$502.9M
Q1 25
$1.1B
$524.2M
Q4 24
$1.2B
$551.9M
Q3 24
$976.9M
$553.9M
Q2 24
$914.1M
$527.9M
Q1 24
$855.1M
$499.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
DAKT
DAKT
Operating Cash FlowLast quarter
$-48.7M
$16.5M
Free Cash FlowOCF − Capex
$14.0M
FCF MarginFCF / Revenue
6.1%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
-0.18×
0.94×
TTM Free Cash FlowTrailing 4 quarters
$61.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
DAKT
DAKT
Q4 25
$-48.7M
$16.5M
Q3 25
$74.3M
$26.1M
Q2 25
$64.0M
$22.9M
Q1 25
$20.3M
$12.0M
Q4 24
$40.4M
$43.3M
Q3 24
$63.2M
$19.5M
Q2 24
$25.0M
$9.5M
Q1 24
$29.1M
$9.5M
Free Cash Flow
ACAD
ACAD
DAKT
DAKT
Q4 25
$14.0M
Q3 25
$73.9M
$21.8M
Q2 25
$18.0M
Q1 25
$7.8M
Q4 24
$38.0M
Q3 24
$63.2M
$14.4M
Q2 24
$6.1M
Q1 24
$5.1M
FCF Margin
ACAD
ACAD
DAKT
DAKT
Q4 25
6.1%
Q3 25
26.5%
10.0%
Q2 25
10.5%
Q1 25
5.2%
Q4 24
18.2%
Q3 24
25.2%
6.4%
Q2 24
2.8%
Q1 24
3.0%
Capex Intensity
ACAD
ACAD
DAKT
DAKT
Q4 25
1.1%
Q3 25
0.1%
2.0%
Q2 25
2.8%
Q1 25
2.8%
Q4 24
2.6%
Q3 24
0.0%
2.2%
Q2 24
1.6%
Q1 24
2.6%
Cash Conversion
ACAD
ACAD
DAKT
DAKT
Q4 25
-0.18×
0.94×
Q3 25
1.03×
1.58×
Q2 25
2.40×
Q1 25
1.07×
Q4 24
0.28×
2.02×
Q3 24
1.93×
Q2 24
0.75×
3.75×
Q1 24
1.76×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

DAKT
DAKT

Live Events Segment$81.5M36%
Transferred At Point In Time$41.9M18%
Limited Configuration$39.2M17%
Other$30.6M13%
Transportation Segment$21.3M9%
Transferred Over Time$8.8M4%
Unique Configuration$6.0M3%

Related Comparisons